1-7 of 7
Francis Ali-Osman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B229: Novel ezatiostat analogues disrupt binding of GSTP1 to all three major MAP kinases (JNK, ERK and p38) and exhibit context-dependent antitumor activity.

Francis Ali-Osman, Tatsunori Okamura, Ryan Turley, Andrew Barker, James G. Keck, Edgardo Laborde, Danying Cai, Robert Mascata
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): B229.
https://doi.org/10.1158/1535-7163.TARG-11-B229
Published: 12 November 2011
View article titled, Abstract B229: Novel ezatiostat analogues disrupt binding of GSTP1 to all three major MAP kinases (JNK, ERK and p38) and exhibit context-dependent antitumor activity.
Journal Articles

Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy

Christina K. Augustine, Hiroaki Toshimitsu, Sin-Ho Jung, Patricia A. Zipfel, Jin S. Yoo, Yasunori Yoshimoto, M. Angelica Selim, James Burchette, Georgia M. Beasley, Nicole McMahon, James Padussis, Scott K. Pruitt, Francis Ali-Osman, Douglas S. Tyler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (7): 2090–2101.
https://doi.org/10.1158/1535-7163.MCT-10-0073
Published: 07 July 2010
View article titled, Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy
Open the PDF for Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma

Christina K. Augustine, Sin-Ho Jung, Insuk Sohn, Jin Soo Yoo, Yasunori Yoshimoto, John A. Olson, Jr., Henry S. Friedman, Francis Ali-Osman, Douglas S. Tyler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (4): 779–790.
https://doi.org/10.1158/1535-7163.MCT-09-0764
Published: 07 April 2010
View article titled, Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma
Open the PDF for Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents

Yasunori Yoshimoto, Christina K. Augustine, Jin S. Yoo, Patricia A. Zipfel, M. Angelica Selim, Scott K. Pruitt, Henry S. Friedman, Francis Ali-Osman, Douglas S. Tyler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (5): 1492–1500.
https://doi.org/10.1158/1535-7163.MCT-06-0718
Published: 18 May 2007
View article titled, Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents
Open the PDF for Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents in another window
Journal Articles

Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma

Jill A. Maxwell, Stewart P. Johnson, Jennifer A. Quinn, Roger E. McLendon, Francis Ali-Osman, Allan H. Friedman, James E. Herndon, II, Katja Bierau, Joseph Bigley, Darell D. Bigner, Henry S. Friedman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (10): 2531–2539.
https://doi.org/10.1158/1535-7163.MCT-06-0106
Published: 13 October 2006
View article titled, Quantitative analysis of O<sup>6</sup>-alkylguanine-DNA alkyltransferase in malignant glioma
Open the PDF for Quantitative analysis of O<sup>6</sup>-alkylguanine-DNA alkyltransferase in malignant glioma in another window
Journal Articles

Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft

C. Lynn Cheng, Stewart P. Johnson, Stephen T. Keir, Jennifer A. Quinn, Francis Ali-Osman, Csaba Szabo, Hongshan Li, Andrew L. Salzman, M. Eileen Dolan, Paul Modrich, Darell D. Bigner, Henry S. Friedman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (9): 1364–1368.
https://doi.org/10.1158/1535-7163.MCT-05-0128
Published: 16 September 2005
View article titled, Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft
Open the PDF for Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft in another window
Journal Articles

Mechanisms of Resistance to 1,3-Bis(2-chloroethyl)-1-nitrosourea in Human Medulloblastoma and Rhabdomyosarcoma

Manny D. Bacolod, Stewart P. Johnson, Francis Ali-Osman, Paul Modrich, Nancy S. Bullock, O. Michael Colvin, Darell D. Bigner, Henry S. Friedman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2002) 1 (9): 727–736.
Published: 01 July 2002
View article titled, Mechanisms of Resistance to 1,3-Bis(2-chloroethyl)-1-nitrosourea in Human Medulloblastoma and Rhabdomyosarcoma
Open the PDF for Mechanisms of Resistance to 1,3-Bis(2-chloroethyl)-1-nitrosourea in Human Medulloblastoma and Rhabdomyosarcoma in another window